(Q37871339)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537349%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

review article

1 reference

title

Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537349%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

0 references

0 references

Juan F Navarro-González

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537349%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Carmen Mora-Fernández

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537349%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Mercedes Muros de Fuentes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537349%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Javier García-Pérez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537349%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

language of work or name

English

0 references

publication date

3 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537349%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Nephrology

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537349%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537349%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537349%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

327-340

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537349%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrneph.2011.51

30 January 2020

exact match

0 references

cites work

Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Defining human diabetic nephropathy on the molecular level: integration of transcriptomic profiles with biological knowledge

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Why is proteinuria an ominous biomarker of progressive kidney disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

How does proteinuria cause progressive renal damage?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Inflammatory process in type 2 diabetes: The role of cytokines.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

mRNA expression of growth factors in glomeruli from diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glom

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Role of inflammation in diabetic complications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

The role of inflammatory cytokines in diabetic nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Interleukin 1 and tumor necrosis factor potentiate angiotensin II- and calcium ionophore-stimulated prostaglandin E2 synthesis in rat renal mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Regulation of renal proximal tubular epithelial cell hyaluronan generation: implications for diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

In situ hybridization of interleukin 6 in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Interleukin-6: an autocrine regulator of mesangial cell growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Detection of serum IL-6 in patients with diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Upregulated IL-18 expression in type 2 diabetic subjects with nephropathy: TGF-beta1 enhanced IL-18 expression in human renal proximal tubular epithelial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Cloning of a new cytokine that induces IFN-gamma production by T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Differential effect of IL-18 on endothelial cell apoptosis mediated by TNF-alpha and Fas (CD95).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Selective regulation of intercellular adhesion molecule-1 expression by interleukin-18 and interleukin-12 on human monocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Interleukin-18 contributes more closely to the progression of diabetic nephropathy than other diabetic complications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Tumor necrosis factor stimulates prostaglandin production and cyclic AMP levels in rat cultured mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Regulation of TNF-alpha-induced reorganization of the actin cytoskeleton and cell-cell junctions by Rho, Rac, and Cdc42 in human endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-alpha stimulation, and effects of a phosphodiesterase inhibitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Pentoxifylline ameliorates renal tumor necrosis factor expression, sodium retention, and renal hypertrophy in diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

The death ligand TRAIL in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

The MIF receptor CD74 in diabetic podocyte injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Role of macrophages in complications of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Proteinuria and activated T-lymphocytes in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Abnormalities in primary granule exocytosis in neutrophils from Type I diabetic patients with nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Increased spontaneous adherence of neutrophils from type 2 diabetic patients with overt proteinuria: possible role of the progression of diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Leukocyte recruitment and vascular injury in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

The role of chemokines and chemokine receptors in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Kidney diseases and chemokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

The effect of angiotensin II receptor blockade on an end-stage renal failure model of type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Blockade of CCR2 ameliorates progressive fibrosis in kidney.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Fractalkine in vascular biology: from basic research to clinical disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Fractalkine and its receptor, CX3CR1, upregulation in streptozotocin-induced diabetic kidneys.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Advanced glycation end-product induces fractalkine gene upregulation in normal rat glomeruli

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Protein overload induces fractalkine upregulation in proximal tubular cells through nuclear factor kappaB- and p38 mitogen-activated protein kinase-dependent pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Expression of the fractalkine receptor (CX3CR1) in human kidney diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

RANTES: a versatile and controversial chemokine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Systemic Immune Mediators and Lifestyle Changes in the Prevention of Type 2 Diabetes: Results From the Finnish Diabetes Prevention Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Flavones mitigate tumor necrosis factor-alpha-induced adhesion molecule upregulation in cultured human endothelial cells: role of nuclear factor-kappa B.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

TNF-alpha activation of arterioles and venules alters distribution and levels of ICAM-1 and affects leukocyte-endothelial cell interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Altered shear stress stimulates upregulation of endothelial VCAM-1 and ICAM-1 in a BMP-4- and TGF-beta1-dependent pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Intercellular Adhesion Molecule-1–Deficient Mice Are Resistant Against Renal Injury After Induction of Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Vascular cell adhesion molecule-1 expression in the renal interstitium of diabetic KKAy mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Correlation between circulating adhesion molecule levels and albuminuria in type-2 diabetic hypertensive patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

A transmembrane tight junction protein selectively expressed on endothelial cells and platelets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Endothelial cell-selective adhesion molecule regulates albuminuria in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Tissue-specific induction of E-selectin in glomeruli is augmented following diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Increased expression of selectins in kidneys of patients with diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Soluble vascular cell adhesion molecule-1 and soluble E-selectin are associated with micro- and macrovascular complications in Type 1 diabetic patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

α-Actinin-4 Is Required for Normal Podocyte Adhesion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Expression of alpha-actinin-4 in human diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Mechanical stretch induces monocyte chemoattractant activity via an NF-kappaB-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Nuclear factor-kappaB activation in diabetic rat kidney: evidence for involvement of P-selectin in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Transcription factor-kappa B (NF-kappa B) and renal disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Prevention of end-stage renal disease due to type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

The next generation of diabetic nephropathy therapies: an update

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Effect of TNF-alpha inhibition on urinary albumin excretion in experimental diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Pentoxifylline improves hemoglobin levels in patients with erythropoietin-resistant anemia in renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Lisofylline, a novel antiinflammatory compound, protects mesangial cells from hyperglycemia- and angiotensin II-mediated extracellular matrix deposition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Pentoxifylline, albumin excretion rate and proteinuria in type I and type II diabetic patients with microproteinuria. Results of a short-term randomized study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Pentoxifylline in management of proteinuria in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Effect of phlebotomy on plasma glucose and insulin concentrations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Antiproteinuric effect of pentoxifylline in patients with diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Effects of pentoxifylline on the urinary protein excretion profile of type 2 diabetic patients with microproteinuria: a double-blind, placebo-controlled randomized trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

[Effect of pentoxifylline on the evolution of diabetic nephropathy].

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.51

Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.

31 March 2020

1 reference

12 December 2020

Involvement of tumor necrosis factor-alpha in the pathogenesis of experimental and human glomerulonephritis.

1 reference

12 December 2020

Tumor necrosis factor induces glomerular damage in the rabbit

1 reference

12 December 2020

Cytokine modulation by PX differently affects specific acute phase proteins during sepsis in rats

1 reference

12 December 2020

Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.

1 reference

12 December 2020

Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients

1 reference

12 December 2020

Increased serum levels of interleukin-18 in patients with diabetic nephropathy

1 reference

12 December 2020

Reduction of macroalbuminuria with pentoxifylline in diabetic nephropathy. Report of three cases

1 reference

12 December 2020

[The cellular immunity indices in diabetic nephropathy]

1 reference

12 December 2020

Comparative analysis of the renoprotective effects of pentoxifylline and vitamin E on streptozotocin-induced diabetes mellitus

1 reference

12 December 2020

Role of macrophages in the pathogenesis of diabetic nephropathy

1 reference

12 December 2020

Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability

1 reference

12 December 2020

[Effect of trental on indices kidney function in diabetes mellitus]

1 reference

12 December 2020

Regulation of renal transport processes and hemodynamics by macrophages and lymphocytes

1 reference

12 December 2020

Pentoxifylline suppression of tumor necrosis factor gene transcription

1 reference

12 December 2020

TNF-alpha increases albumin permeability of isolated rat glomeruli through the generation of superoxide

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2011.51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537349%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference